Browsing by Author "Kesikli, Altug"
Now showing items 1-1 of 1
-
Paclitaxel, Not Bevacizumab, Was Primarily Responsible for the Favorable Effects Seen in the RIBBON-2 Trial
Kesikli, Altug; Kilickap, Saadettin (AMER SOC CLINICAL ONCOLOGY, 2012)…